期刊文献+

MAGE基因mRNA在非小细胞肺癌中的表达 被引量:2

mRNA EXPRESSIONS OF MAGE GENES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
下载PDF
导出
摘要 目的 :检测 MAGE- 1、- 2、- 3、- 4基因 m RNA在非小细胞肺癌 (NSCL C)中的表达情况。方法 :采用逆转录 -聚合酶链反应(RT- PCR)方法对 2 8例 NSCL C患者的肺癌组织进行 MAGE- 1、- 2、- 3、- 4 m RNA表达的检测。结果 :2 8例肺癌标本中 MAGE-1、- 2、- 3、- 4的阳性表达率分别为 35 .7% (10 /2 8)、4 2 .9% (12 /2 8)、5 3.6 % (15 /2 8)、35 .7% (10 /2 8) ;4种基因至少有一种表达的几率是 89.3% (2 5 /2 8) ;两种或两种以上同时表达几率是 5 7.1% (16 /2 8)。非肺癌患者肺组织 4种 MAGE基因表达均为 0 %。结论 :非小细胞肺癌中 MAGE- 1、- 2、- 3、- 4基因高表达 ,非肺癌肺组织无表达 ,提示 MAGE基因可用于肺癌的主动免疫治疗。 Objective:To investigate the expressions of MAGE-1,-2,-3 and -4 genes in lung cancer samples of patients with non-small cell lung cancer(NSCLC) at mRNA level.Methods:28 samples of lung cancer and 64 stations of lymph nodes from 28 patients with NSCLC were studied to detect mRNA for MAGE-1, -2,-3 and -4 genes by using reverse transcription-polymerase chain reaction assay (RT-PCR).Result:Of the 28 lung cancer samples,the MAGE-1,-2,-3 and -4 were expressed at mRNA level in 35.7%(10/28),42.9%(12/28),53.6%(15/28) and 35.7%(10/28) respectively. At least one of these genes was expressed in 89.3%(25/28) in of the samples. Two or more of these genes were expressed in 57.1%(16/28)of the samples. In the samples of lung of the patients without lung cancer, the MAGE-1,-2,-3 and -4 were expressed at mRNA level in 0%.Conclusion:MAGE-1,-2,-3,-4 are expressed at a high precentage in lung cancer,and all of these genes are negative in the adjacent non-tumorous lung tissue. These results indicate the possiblity of a future specific immunotherapy for lung cancer based on the MAGE antigens.
出处 《广西医科大学学报》 CAS 北大核心 2005年第1期9-12,共4页 Journal of Guangxi Medical University
关键词 非小细胞肺癌 MAGE基因 逆转录-聚合酶链反应 non-small cell lung cancer MAGE genes RT-PCR
  • 相关文献

参考文献11

  • 1Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res, 1998,58(2):743-752.
  • 2Li J, Yang Y, Fujie T, et al. Expression of MAGE gene family in human gastric carcinoma. Anticancer Res,1997,17(5A):3 559-3 563.
  • 3D'Cunha J,Corfits AL,Herndon JE 2nd,et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer:preliminary results of Cancer and Leukemia Group B Trial 9 761. J Thorac Cardiovasc Surg, 2002,123(3):484-491.
  • 4Mountain CF. Revisions in international system for staging lung cancer. Chest,1997,111(6):1 710-1 717.
  • 5Salerno CT, Frizelle S, Niehans GA, et al. Detection of occult micrometastasis in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.Chest,1998,113(6):1 526-1 532.
  • 6Quillien V, Raoul JL, Heresbach D, et al. Expression of MAGE genes in esophageal squamous cell carcinoma.Anticancer Res, 1997,17 (1A) : 387-391.
  • 7Yoshimatsu T, Yoshino I, Ohgami A, et al. Expression of the melanoma antigen-encoding gene in human lung cancer. J SurgOncol, 1998,67(2):126-129.
  • 8Tahara K,Mori M ,Sadanaga N ,et al. Expression of MAGE gene family in human hepatocellular carcinoma.Cancer,1999,15(6):1 234-1 240.
  • 9Fujie T,Tahara K,Tanaka F,et al. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific antitu-morcytotoxic T lymphocytes. Int J Cancer, 1999, 80(2):169-172.
  • 10JF Toso, C Oei, F Oshidari, et al. MAGE-1 specific precursor cytotoxic T lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res, 1996 (1), 56:16-20.

同被引文献10

  • 1Van der Bruggen P,Traver San C,Chomez P,et al.A gene edcoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254(5038):1643 ~ 1647.
  • 2Inoue H,Mori M,Li J,et al.Human esophageal carcinomas frequently erpress the tumor-rejection antigens of MAGE genes[J].Int J Cancer,1995,63 (4):523 ~ 526.
  • 3Mou DC,Cai SL,Peng JR,et al.Evaluation of MAGE-1 and MAGE -3 as tumourspecific markers to detect blood dissemination of hepatocellular carcinoma ceus[J].Br J Cancer,2002,86 (1):110 ~116.
  • 4De Plaen E,Arden K,Traversari C,et al.Strulture,chromosomal localiztation and expvession of twelve genes of the MAGE family[J].Immunogenetics,1994,40:360 ~ 369.
  • 5Jemal A,Bray F,Center MM,et al.Global cancer statistics [J].CA Cancer J Clin,2011,61(2):69-90.
  • 6Wilking NJB. A pan-European comparison regarding patient access to cancer drugs[Z].Karolinska Institute in collaboration with Stockholm School of Economics,2005:331-7 521.
  • 7Pantel K,Izbicki J,Passlick B,er al.Frenquency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases[J].Lancet,1996,9002(347):649-653.
  • 8Nishida S,Kitamura K,Ichikawa D,et al.Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer [J].Anticancer Res,2000,20(3B):2 155-2 159.
  • 9van der Bruggen P,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma [J].Science,1991,254(5038):1 643-1 647.
  • 10杨翠红,钱振超.人类黑色素瘤抗原的研究进展[J].国外医学(免疫学分册),1998,21(2):68-71. 被引量:6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部